Ultroid Technologies, Inc.
Quick, Easy, Painless and Proven Solution for HD

UltroidNews

22
May

Ultroid has added an online ordering system on their website at: http://ultroid.com/distribution/order-online. Orders are processed the same business day if submitted before 12 PM EST. Orders received after this time will be processed the next business day.

Category : UltroidNews | Blog
19
Jan

The Ultroid® Solution

Posted by admin Comments Off

The Ultroid® Hemorrhoid Management System is cleared by the FDA for the treatment of ALL grades of internal HD (hemorrhoidal disease).  The Ultroid® System creates a chemical reaction at the problem area that quickly, painlessly and permanently eliminates the hemorrhoid.

Unlike surgery, the Ultroid System is a non-invasive and painless procedure performed in your doctors office without anesthesia, fasting or any other preparation. It takes about 10 minutes and allows you to leave immediately after, resume your normal activities and get back into the full active lifestyle you deserve. 

Many of us will have an experience with HD or know someone that does. In fact, 75% of people in the United States will experience symptoms of HD at some point in their lives. Don’t wait until surgery is your only option. Ask your doctor about the Ultroid System and do something about it. There is no reason you have to live with the pain or endure a painful and expensive surgery to eliminate the problem.

Category : UltroidNews | Blog
15
Dec

Former Johnson & Johnson Senior Executive Wycliffe (Cliff) McIntosh to Lead Innovative Medical Device Company
St. Petersburg, FL Dec. 15, 2009 — Ultroid® Technologies, Inc., a leader in non-invasive, low cost, micro current technologies announced today that Wycliffe (Cliff) McIntosh has joined the company to serve as Chief Executive Officer.

Cliff McIntosh brings significant medical device experience to Ultroid Technologies, Inc. Most recently, he was President of the highly successful Johnson & Johnson (JNJ) Diabetes Institute where he created a best in class global organization dedicated to training health care professionals. His responsibilities also included successful commercial leadership roles in international sales & marketing, finance, strategic planning and general management spanning over 24 years with the company.

“We are excited that Cliff has joined the Ultroid Technologies, Inc. executive team,” said Dr. Howard Howell, Board Chairman of Ultroid Technologies, Inc., “and we are looking forward to Cliff’s leadership, expertise, and years of international experience to complete Ultroid’s global marketing strategy. He brings a broad range of leadership qualities, an in depth understanding of medical devices and a strong commitment to excellence. These attributes, along with his compassion to help people, make him the perfect CEO to lead the Ultroid team in its rapid growth and success in the national and international medical device arena.”

Over the past 15 years, Cliff held several commercial leadership positions with Johnson & Johnson (JNJ). He was an International Vice President and directly responsible for several diabetes care medical device companies in Europe, Middle East & Africa and Asia/Pacific, where he led consumer and professional marketing development, launched innovative new products, achieved market share leadership and developed high performance teams across many regions of the world. As a past Board member of the European Diagnostic Manufacturing Association and the British In-Vitro Diagnostic Association, he led several EU initiatives across Europe addressing product safety. Cliff is a graduate of Fordham University and holds several leadership certificates from prestigious institutions including the University of Pennsylvania.

“I am extremely excited to join the Ultroid team at this time in the company’s evolution. We have a unique opportunity to create a new standard of care for people suffering from hemorrhoid disease and make a tremendous impact on their quality of life. I look forward to the challenges in building commercial value and leveraging the great technology.”

About Ultroid Technologies, Inc.

Ultroid Technologies, Inc. is a leader in non-invasive, low cost, micro current technologies in the United States. Its flagship product is the Ultroid® Hemorrhoid Management System, a non-invasive, painless, and low cost treatment. This procedure for the treatment of hemorrhoidal disease (HD) is applicable for all four grades of internal hemorrhoids. The Ultroid Procedure is effective in over 40,000 procedures and has over a 95% effective rate with no reported complications. The Ultroid System replaces over-the-counter creams and painful surgeries by providing a quick, painless, and permanent solution without interrupting daily activities.

The Company’s website is www.Ultroid.com. The brand names referenced in this press release are trademarks of Ultroid Technologies, Inc. its affiliated companies, customers, or other third parties. The company markets and manufactures the Ultroid Hemorrhoid Management System.

Safe Harbor Statements
This press release may contain forward-looking statements reflecting management’s current expectations regarding future results of operations, economic performance, financial condition and achievements of the Company. The forward-looking statements are based on the assumption that operating performance will continue to exponentially grow in line with recent trends and consistent with distribution expansion. Management believes these assumptions to be reasonable but there is no assurance that they will prove to be accurate. Forward-looking statements, specifically those concerning future performance are subject to certain risks and uncertainties, and actual results may differ materially. These risks and uncertainties are detailed from time to time in the Company’s filings. The Company undertakes no obligation to publicly update or revise any forward-looking statements.

Contact:

Ultroid Technologies, Inc., St. Petersburg
Mike Wodstrchill, 877-858-0555
Fax: 727-898-0716
www.Ultroid.com

Category : UltroidNews | Blog
21
May

ST PETERSBURG, FLORIDA, MAY 21, 2009
Dr. Allison Karolak has been named Medical Director of Ultroid Technologies, Inc., a fast-growing U.S. medical device company, and its parent company, Vascular Technologies, Inc., owner of Ultroid.

In Good Company

Dr. Karolak represents the latest addition to our team of professionals. She brings a unique perspective to our company as both a physician and a patient. Dr. Karolak is, and will always remain, a patient advocate. As a family physician, she touched the lives of many with her profound caring and exceptional clinical skills but felt compelled to bring relief to patients on a national scale. Dr. Karolak is passionate about her quest to assist in relieving millions of patients from the burden of hemorrhoidal disease. As a mother of two small children, she suffered silently for years without treatment of internal hemorrhoids due to the lack of desirable treatment options. Then, Dr. Karolak discovered Ultroid. It changed her life and ignited a desire and sense of responsibility to get the word out to both physicians and patients that finally there is an effective, painless treatment for internal hemorrhoids.
Dr. Karolak is a proud graduate of the University of Medicine and Dentistry of New Jersey-School of Osteopathic Medicine. She deeply believes in the principle of treating each and every patient with a holistic approach, understanding that not only are they affected physically by their illnesses but psychologically and socially as well. Dr. Karolak completed her internship at Union Hospital, an affiliate of the Saint Barnabas Health System and her Family Medicine residency at Christ Hospital in Jersey City, New Jersey. She is board certified in Family Practice and Osteopathic Manipulative Treatment. Dr. Karolak is a proud member of the American Osteopathic Association and the American College of Osteopathic Family Physicians.

Positive Outlook
“It is a win-win-win-win situation, really no one loses,” declares Dr. Karolak, “The patient gets a painless treatment, the doctor has an attractive treatment option, he gets paid, and it’s cheaper than the other modalities for the insurance companies. I was fascinated for several reasons.”

Vision and Agenda
Dr. Karolak shares her vision and agenda, “My top three priorities are clinical research, training for everyone who touches Ultroid and awareness of our product for both doctors and patients.” Karolak details her plan, “It is my goal to recruit physicians across the country to participate in randomized, multi-center, prospective studies comparing the Ultroid® Hemorrhoid Management System with the other treatment modalities.” Dr. Karolak plans on educating within the company as well, “I will be working with our staff at every level and with our distributors and their representatives, to educate them with the facts about our product. I plan to design and implement training manuals for each department of our company with the facts about Ultroid that are applicable to their job.”

Changing Medicine

“We believe that through education,” explains Dr. Karolak, “we can change the public’s perception of hemorrhoids as a taboo subject that affects individuals in the privacy of their bathrooms in to a disease that affects millions on a daily ongoing basis.” Dr. Karolak stresses, “It’s time to talk about it because now there is something to do about it. U2 can change your life!”

About Vascular and Ultroid Technologies, Inc.

Vascular Technologies, Inc. is one of the fastest growing medical device companies in the United States. Its principal product is the Ultroid® Hemorrhoid Management System, a non-invasive, pain-free, and lower cost treatment than current procedures for the treatment of hemorrhoid disease (HD). In over 40,000 procedures the Ultroid® System has had over a 95% effective rate, and replaces ineffective over-the-counter creams and painful surgeries that can be accompanied by infection and prolonged recovery. The Ultroid® Procedure can be performed by any physician, regardless of specialty, in their office, in usually less than 10 minutes. Patients are able to resume their normal daily activities immediately, versus the several month recovery often associated with current laser and other surgical treatments. the Ultroid System is the only FDA-cleared Medical Device for the treatment of all grades of hemorrhoids and accepted by most insurers and Medicare.

The Company’s website is www.Ultroid.com. The brand names referenced in this press release are trademarks of Vascular Technologies, Inc. and Ultroid Technologies, Inc. its affiliated companies, customers, or other third parties. The company manages web video enabled training clinics, Ultroid Wellness Centers and markets and manufactures the Ultroid® Hemorrhoid Management System.

Safe Harbor Statements
This press release may contain forward-looking statements reflecting management’s current expectations regarding future results of operations, economic performance, financial condition and achievements of the Company. The forward-looking statements are based on the assumption that operating performance will continue to exponentially grow in line with recent trends and consistent with distribution expansion. Management believes these assumptions to be reasonable but there is no assurance that they will prove to be accurate. Forward-looking statements, specifically those concerning future performance are subject to certain risks and uncertainties, and actual results may differ materially. These risks and uncertainties are detailed from time to time in the Company’s filings. The Company undertakes no obligation to publicly update or revise any forward-looking statements.

Contact Information:
Ultroid Technologies, Inc.
Mike Wodstrchill
Tel: 877 858-0555

Category : UltroidNews | Blog
25
Apr

April 25, 2008 — No one talks about it but for the millions of Americans that have ever suffered from hemorrhoid irritation putting the problem out of their minds is easier said than done. Hemorrhoidal disease (HD) is a frequent, disabling and painful condition.

Ultroid® Technologies, a St. Petersburg, Florida company, has developed a painless, non-surgical product for doctors to treat hemorrhoids and is getting the word out that hemorrhoids don’t have to be a problem. The Ultroid® Hemorrhoid Management System, also available in a small mobile unit, allows doctors to provide outpatient treatments that only last eight to twelve minutes. Patients can resume their regular activities, such as work, tennis and golf, the same day. They can have their embarrassing problem taken care of painlessly, and without putting their lives on hold.

Category : UltroidNews | Blog